The Granulocyte-Colony Stimulating Factor (G-CSF) market is witnessing robust expansion, driven by rising cancer incidences, advancements in biotechnology, and increasing demand for supportive care in oncology and hematology. According to The Insight Partners, the market size stood at approximately US$ 2.81 Billion in 2024 and is projected to reach US$ 4.48 Billion by...